The Inhibition of the Y-Box binding protein-1 Signaling Pathway by Fisetin inhibits the DNA Double-Strand Break Repair and induces Radiation Sensitization in triple-negative Breast Cancer Cells

被引:0
|
作者
Khozooei, S. [1 ,2 ]
Dimitrov, E. [1 ,2 ]
Lettau, K. [1 ,2 ]
Zips, D. [1 ,2 ]
Toulany, M. [1 ,2 ]
机构
[1] Univ Tubingen, Klin Radioonkol, Sekt Strahlenbiol & Mol Umweltforsch, Tubingen, Germany
[2] Deutsch Krebsforschungszentrum DKFZ, Partnerstandort Tubingen, Deutsches Konsortium Translat Krebsforsch DKTK, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P15-16
引用
收藏
页码:S206 / S206
页数:1
相关论文
共 50 条
  • [41] Nintedanib induces antitumor effects in triple-negative breast cancer cells by targeting SHP-1/p-STAT3-mediated signaling pathway
    Liu, Chun-Yu
    Lee, Chia-Han
    Huang, Chun-Teng
    Chu, Pei-Yi
    Wang, Wan-Lun
    Tseng, Ling-Ming
    Shiau, Chung-Wai
    Chen, Kuen-Feng
    CANCER RESEARCH, 2016, 76
  • [42] The parthenolide analog DMAPT induces X-ray sensitization of radiation resistant lung cancer cells through inhibition of NF-\#954;B dependent split dose recovery and DNA double strand break repair
    Mendonca, Marc
    Estabrook, Neil
    Watson, Christopher
    Miller, Douglas
    Chin-Sinex, Helen
    Borgman, Anthony
    Ownsbey, Mischa
    Smolen, Nicholas
    Losch, Adam
    Gilley, David
    Huda, M. Nazmul
    Crooks, Peter
    Sweeney, Christopher
    CANCER RESEARCH, 2009, 69
  • [43] DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway
    Seto-Tetsuo, Fumi
    Arioka, Masaki
    Miura, Koichi
    Inoue, Takeru
    Igawa, Kazunobu
    Tomooka, Katsuhiko
    Takahashi-Yanaga, Fumi
    Sasaguri, Toshiyuki
    ONCOGENE, 2021, 40 (37) : 5579 - 5589
  • [44] DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway
    Fumi Seto-Tetsuo
    Masaki Arioka
    Koichi Miura
    Takeru Inoue
    Kazunobu Igawa
    Katsuhiko Tomooka
    Fumi Takahashi-Yanaga
    Toshiyuki Sasaguri
    Oncogene, 2021, 40 : 5579 - 5589
  • [45] Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
    Stratford, Anna L.
    Fry, Christopher J.
    Desilets, Curtis
    Davies, Alastair H.
    Cho, Yong Y.
    Li, Yvonne
    Dong, Zigang
    Berquin, Isabelle M.
    Roux, Philippe P.
    Dunn, Sandra E.
    BREAST CANCER RESEARCH, 2008, 10 (06):
  • [46] Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
    Anna L Stratford
    Christopher J Fry
    Curtis Desilets
    Alastair H Davies
    Yong Y Cho
    Yvonne Li
    Zigang Dong
    Isabelle M Berquin
    Philippe P Roux
    Sandra E Dunn
    Breast Cancer Research, 10
  • [47] Eugenol modulates the NOD1-NF-κB signaling pathway via targeting NF-κB protein in triple-negative breast cancer cells
    Shi, Xiaoyu
    Zhang, Weiwei
    Bao, Xiao
    Liu, Xiaozhu
    Yang, Ming
    Yin, Chengliang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [48] Advanced quantitative mass-spectrometry-based SILAC proteome profiling of Y-box binding protein-1 (YB-1) overexpressing breast cancer cells unravels proteins involved in metastasis
    Lim, Jia Pei
    Nair, Sunitha
    Shyamasundar, Sukanya
    Gunaratne, Jayantha
    Bay, Boon Huat
    CANCER RESEARCH, 2018, 78 (13)
  • [49] Preclinical and clinical studies of novel breast cancer drugs targeting molecules involved in protein kinase C signaling, the putative metastasis-suppressor gene cap43 and the Y-box binding protein-1
    Fujii, Teruhiko
    Yokoyama, Goro
    Takahashi, Hiroki
    Toh, Uhi
    Kage, Masayoshi
    Ono, Mayumi
    Shirouzu, Kazuo
    Kuwano, Michihiko
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (06) : 528 - 537
  • [50] Depletion of DNA damage binding protein 2 sensitizes triple-negative breast cancer cells to poly ADP-ribose polymerase inhibition by destabilizing Rad51
    Zhao, Lin
    Si, Cheng-Shuai
    Yu, Yue
    Lu, Jian-Wei
    Zhuang, Yan
    CANCER SCIENCE, 2019, 110 (11) : 3543 - 3552